201 filings
Page 4 of 11
S-8
8nncdhi6
21 Mar 22
Registration of securities for employees
8:38am
8-K
qx7p421hx9123
21 Mar 22
UroGen Pharma Reports Fourth Quarter and Full-year 2021 Financial Results
8:11am
8-K
rik7qcdw
8 Mar 22
Entry into a Material Definitive Agreement
9:13am
8-K
67jj5i4dq5b704k2b
15 Nov 21
UroGen Pharma Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
8:10am
8-K
uwwwt
10 Nov 21
Other Events
5:08pm
8-K
actxkwm8
13 Sep 21
Other Events
8:15am
S-8
o9a5jl374l8og8
5 Aug 21
Registration of securities for employees
4:45pm
8-K
sq6i0raos p397
4 Aug 21
UroGen Pharma Reports Second Quarter 2021 Financial Results and Recent Corporate
8:11am
8-K
m5dwahfb0fov0
14 Jul 21
UroGen Pharma Reports Strong Preliminary Jelmyto® Sales for Second Quarter 2021
8:11am
8-K
2lk5zzykcvykbnpgk
8 Jun 21
Departure of Directors or Certain Officers
2:43pm
8-K
z8lip yj2sx8r
13 May 21
UroGen Pharma Reports First Quarter 2021 Financial Results and Recent Corporate Developments
7:40am
DEFA14A
hgrl0bp
28 Apr 21
Additional proxy soliciting materials
4:04pm
8-K
oivfkn
18 Mar 21
UroGen Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments
8:13am
8-K
j7cgl
18 Mar 21
UroGen Pharma Announces $75 Million of Non-Dilutive Funding from RTW Investments
8:10am